Nitrogen ?
Founder & CEO

Everygene provides a direct‑to‑consumer, at‑home genetic screening that analyzes 84 medically actionable genes linked to serious but treatable diseases. Users collect a cheek swab, which is sequenced in a CLIA‑certified lab and interpreted in partnership with Mass General Brigham, delivering a clinician‑reviewed report, downloadable genome file, and free counseling for any positive findings.
Funding not disclosed

Founder & CEO
Many adults remain unaware of genetic risks for serious but treatable diseases because clinical genetic testing is typically accessed only through a physician referral, often after symptoms appear. This delays preventive interventions and leaves individuals without actionable health information.
Everygene offers a direct-to-consumer, one‑time at‑home genetic screening that analyzes 84 medically actionable genes linked to conditions such as hereditary cancers and cardiovascular disorders. Users collect a cheek swab, which is sequenced in a CLIA‑certified laboratory (Broad Clinical Labs) and interpreted in collaboration with Mass General Brigham, meeting hospital‑grade standards. Results are delivered via a secure portal within 4–6 weeks, including a downloadable VCF file and a clear, clinician‑reviewed report. For any positive finding, a licensed genetic counselor provides a free 30‑minute session to explain the result and outline next steps, while negative results give users peace of mind without further follow‑up.
The service targets health‑conscious adults who want proactive insight into their genetic risk for serious, treatable conditions, especially those without prior genetic testing or a current medical diagnosis.